Literature DB >> 21220114

Helix 11 dynamics is critical for constitutive androstane receptor activity.

Edward Wright1, Scott A Busby, Sarah Wisecarver, Jeremy Vincent, Patrick R Griffin, Elias J Fernandez.   

Abstract

The constitutive androstane receptor (CAR) transactivation can occur in the absence of exogenous ligand and this activity is enhanced by agonists TCPOBOP and meclizine. We use biophysical and cell-based assays to show that increased activity of CAR(TCPOBOP) relative to CAR(meclizine) corresponds to a higher affinity of CAR(TCPOBOP) for the steroid receptor coactivator-1. Additionally, steady-state fluorescence spectra suggest conformational differences between CAR(TCPOBOP):RXR and CAR(meclizine):RXR. Hydrogen/deuterium exchange (HDX) data indicate that the CAR activation function 2 (AF-2) is more stable in CAR(TCPOBOP):RXR and CAR(meclizine):RXR than in CAR:RXR. HDX kinetics also show significant differences between CAR(TCPOBOP):RXR and CAR(meclizine):RXR. Unlike CAR(meclizine):RXR, CAR(TCPOBOP):RXR shows a higher overall stabilization that extends into RXR. We identify residues 339-345 in CAR as an allosteric regulatory site with a greater magnitude reduction in exchange kinetics in CAR(TCPOBOP):RXR than CAR(meclizine):RXR. Accordingly, assays with mutations on CAR at leucine-340 and leucine-343 confirm this region as an important determinant of CAR activity. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220114      PMCID: PMC3032979          DOI: 10.1016/j.str.2010.11.008

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  30 in total

1.  The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism.

Authors:  P Wei; J Zhang; M Egan-Hafley; S Liang; D D Moore
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

Review 2.  Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications.

Authors:  W Bourguet; P Germain; H Gronemeyer
Journal:  Trends Pharmacol Sci       Date:  2000-10       Impact factor: 14.819

3.  Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism.

Authors:  M Gangloff; M Ruff; S Eiler; S Duclaud; J M Wurtz; D Moras
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

4.  Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.

Authors:  Edward Wright; Jeremy Vincent; Elias J Fernandez
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

5.  The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR.

Authors:  I Tzameli; P Pissios; E G Schuetz; D D Moore
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

Authors:  Jang Hyun Choi; Alexander S Banks; Jennifer L Estall; Shingo Kajimura; Pontus Boström; Dina Laznik; Jorge L Ruas; Michael J Chalmers; Theodore M Kamenecka; Matthias Blüher; Patrick R Griffin; Bruce M Spiegelman
Journal:  Nature       Date:  2010-07-22       Impact factor: 49.962

7.  Prediction of the tissue-specificity of selective estrogen receptor modulators by using a single biochemical method.

Authors:  Susie Y Dai; Michael J Chalmers; John Bruning; Kelli S Bramlett; Harold E Osborne; Chahrzad Montrose-Rafizadeh; Robert J Barr; Yong Wang; Minmin Wang; Thomas P Burris; Jeffrey A Dodge; Patrick R Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

8.  HD desktop: an integrated platform for the analysis and visualization of H/D exchange data.

Authors:  Bruce D Pascal; Michael J Chalmers; Scott A Busby; Patrick R Griffin
Journal:  J Am Soc Mass Spectrom       Date:  2008-12-06       Impact factor: 3.109

9.  Partial agonists activate PPARgamma using a helix 12 independent mechanism.

Authors:  John B Bruning; Michael J Chalmers; Swati Prasad; Scott A Busby; Theodore M Kamenecka; Yuanjun He; Kendall W Nettles; Patrick R Griffin
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

10.  The Deuterator: software for the determination of backbone amide deuterium levels from H/D exchange MS data.

Authors:  B D Pascal; M J Chalmers; S A Busby; C C Mader; M R Southern; N F Tsinoremas; P R Griffin
Journal:  BMC Bioinformatics       Date:  2007-05-16       Impact factor: 3.169

View more
  15 in total

Review 1.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

Review 2.  Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Mol Pharmacol       Date:  2012-08-06       Impact factor: 4.436

3.  Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers.

Authors:  Balananda-Dhurjati K Putcha; Edward Wright; Joseph S Brunzelle; Elias J Fernandez
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 4.  Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor.

Authors:  Sergio C Chai; Wenwei Lin; Yongtao Li; Taosheng Chen
Journal:  Drug Discov Today       Date:  2019-02-04       Impact factor: 7.851

Review 5.  Differential hydrogen/deuterium exchange mass spectrometry analysis of protein-ligand interactions.

Authors:  Michael J Chalmers; Scott A Busby; Bruce D Pascal; Graham M West; Patrick R Griffin
Journal:  Expert Rev Proteomics       Date:  2011-02       Impact factor: 3.940

6.  Mapping allostery through computational glycine scanning and correlation analysis of residue-residue contacts.

Authors:  Quentin R Johnson; Richard J Lindsay; Ricky B Nellas; Elias J Fernandez; Tongye Shen
Journal:  Biochemistry       Date:  2015-02-06       Impact factor: 3.162

7.  Increased Molecular Flexibility Widens the Gap between K i and K d values in Screening for Retinoid X Receptor Modulators.

Authors:  Masaki Watanabe; Mariko Nakamura-Nakayama; Michiko Fujihara; Mayu Kawasaki; Shogo Nakano; Hiroki Kakuta
Journal:  ACS Med Chem Lett       Date:  2022-01-21       Impact factor: 4.345

8.  Agonist ligands mediate the transcriptional response of nuclear receptor heterodimers through distinct stoichiometric assemblies with coactivators.

Authors:  Mark Remec Pavlin; Joseph S Brunzelle; Elias J Fernandez
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

Review 9.  Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.

Authors:  Peter Oladimeji; Hongmei Cui; Chen Zhang; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-06-23       Impact factor: 4.481

10.  The Promiscuity of Allosteric Regulation of Nuclear Receptors by Retinoid X Receptor.

Authors:  Alexander K Clark; J Heath Wilder; Aaron W Grayson; Quentin R Johnson; Richard J Lindsay; Ricky B Nellas; Elias J Fernandez; Tongye Shen
Journal:  J Phys Chem B       Date:  2016-04-25       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.